Rhinitis, Allergic: all 1,042 studies
Page 11 of 11. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.
- Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent AsthmaTerminatedNCT00295737Not applicable
- The Effects of OC000459 on Nasal MediatorsCompletedNCT00290381Phase 1/2
- Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy AsthmaStatus unknownNCT00286416Not applicable
- Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)CompletedNCT00261287Phase 3
- Perennial Allergic Rhinitis In Pediatric SubjectsCompletedNCT00257595Phase 3
- Study Of Perennial Allergic Rhinitis In PediatricsCompletedNCT00253058Phase 3
- A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) AllergyCompletedNCT00250263Phase 4
- Safety and Efficacy Study of rEV131 in Allergic RhinitisStatus unknownNCT00247520Phase 1/2
- Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic RhinoconjunctivitisCompletedNCT00232518Not applicable
- Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic RhinitisCompletedNCT00227058Not applicable
- Study In Adults And Adolescents With Seasonal Allergic Rhinitis.CompletedNCT00225823Phase 3
- Long Term Safety Of GW685698X Via Nasal BiopsyCompletedNCT00224523Phase 3
- Seasonal Allergic Rhinitis and Driving AbilityTerminatedNCT00223587Phase 4
- The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure UnitCompletedNCT00209365Not applicable
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)CompletedNCT00197262Phase 3
- Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic RhinitisCompletedNCT00189449
- Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)CompletedNCT00163514Phase 3
- Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)CompletedNCT00163501Phase 3
- Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)CompletedNCT00163488Phase 3
- LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)CompletedNCT00160589Phase 4
- POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)CompletedNCT00160537Phase 4
- Impact in Off-spring of Mothers After Perinatal Daily Intake of a ProbioticCompletedNCT00159523Not applicable
- A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)CompletedNCT00157937Phase 4
- EWO1 in Persistent Allergic Rhinitis PatientsStatus unknownNCT00153595Phase 2/3
- Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic RhinitisCompletedNCT00152412Phase 2
- Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and AsthmaCompletedNCT00135642Phase 3
- Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen HayfeverCompletedNCT00135629Phase 3
- An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic RhinitisCompletedNCT00132925Phase 3
- Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of ActionCompletedNCT00118729Phase 3
- Nasal Ocular Reflexes Contribute to Eye SymptomsCompletedNCT00117832Not applicable
- A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In PediatricsCompletedNCT00116883Phase 3
- A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and AdultsCompletedNCT00116818Phase 3
- Study In Adults And Adolescents With Seasonal Allergic RhinitisCompletedNCT00115622Phase 3
- 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic RhinitisCompletedNCT00115089Phase 2
- Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal SprayCompletedNCT00109486Phase 3
- Perennial Allergic Rhinitis Study In Pediatric SubjectsCompletedNCT00108914Phase 3
- Seasonal Allergic Rhinitis In Pediatric SubjectsCompletedNCT00107757Phase 3
- A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).CompletedNCT00103454Phase 3
- An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)CompletedNCT00092885Phase 3
- Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)CompletedNCT00092105Phase 3
- Nasal Irritation Study: Individual Factors in Nasal Irritant SensitivityCompletedNCT00041821Not applicable
- Pollutant Altered Allergic ResponsesCompletedNCT00011440